Inogen, Inc. INGN announced preliminary revenues for the fourth quarter and full year 2024 on Monday. Following the robust ...

Stifel Nicolaus analyst Mathew Blackman maintained a Hold rating on Inogen (INGN – Research Report) yesterday and set a price target of ...

The Company will report its official fourth quarter and full year 2024 financial results after the market closes on Tuesday, ...

NORTHAMPTON, MA / ACCESSWIRE / January 13, 2025 / Inogen Alliance: Inogen Alliance announces a new Chair of the Board of ...

Check the time stamp on this data. Updated AI-Generated Signals for Inogen Inc (INGN) available here: INGN. Type a few ...

Inogen, Inc. INGN recently announced the FDA 510(k) clearance for the SIMEOX 200 Airway Clearance Device. The clearance is likely to expand INGN’s ability to market the device and meet the ...

Inogen, Inc. INGN is well-poised for growth in the coming quarters, courtesy of high prospects in the portable oxygen concentrator (POC) space. The optimism, led by solid second-quarter 2024 ...

This cautious approach reflects the need for further clarity on how Inogen will address its ongoing business challenges and sustain overall growth. Matson covers the Healthcare sector, focusing on ...

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it has ...

NORTHAMPTON, MA / ACCESSWIRE / January 15, 2025 / Inogen Alliance The COP29 conference in Baku, Azerbaijan, brought together leaders, experts, and stakeholders from across the globe to tackle some of ...

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced unaudited preliminary revenue results for the ...